Ayala Pharmaceuticals, Inc.
ADXSDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001100397
Ayala Pharmaceuticals, Inc. was delisted in 2025; its insiders filed their last Form 4 on Mar 6, 2024; no institution reported holding it in 13F filings for Q2 2025; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 0
- Q2 2025, −1 vs. previous quarter
- 13F value
- $0
- Reported value at the end of Q2 2025
- Superinvestors holding
- 0
- At the end of Q2 2025
Superinvestors holding ADXS, Q2 2025
No superinvestor reported holding ADXS at the end of Q2 2025.
Latest insider trades
Open-market purchases and sales by Ayala Pharmaceuticals, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 21, 2023 (view filing)9:04 AM ET | Nov 17 | 4 days | Israel Biotech Fund I, L.P. and 4 others10% Owner | PPurchase | +43.8M | – | – | –27.6M after | Derivative10 lots |
| Oct 31, 2023 (view filing)7:08 AM ET | Oct 18 | 13 daysLate | Israel Biotech Fund I, L.P. and 4 others10% Owner | PPurchaseCommon Stock, par value $0.001 per share | +1.32M | $0.00 | $0 | New position1.09M after | 2 lots |
| Sep 29, 2023 (view filing)6:13 AM ET | Sep 1 | 28 days | Israel Biotech Fund I, L.P. and 4 others10% Owner | PPurchase | +1.74M | – | – | –434.8K after | AmendedDerivative2 lotsPrice outlierDuplicate filing |
| Sep 11, 2023 (view filing)12:44 PM ET | Sep 1 | 10 daysLate | Israel Biotech Fund I, L.P. and 1 other10% Owner | PPurchase | +1.74M | – | – | –434.8K after | Derivative2 lotsPrice outlier |
Top 10 13F holders, Q2 2025
The largest institutional positions in Ayala Pharmaceuticals, Inc. at the end of Q2 2025; share changes are against Q1 2025.
No institution reported holding ADXS in 13F filings for Q2 2025.